A new preclinical model for thymic cancer developed by Weill Cornell Medicine investigators has revealed insights into how a common mutation found in thymic epithelial tumors sparks their formation.
Back to News
Weill Cornell MedicineOffice of External Affairs Phone: (646) 962-9476